Related Experiment Video
Updated: Apr 23, 2026
10:30
Visualization of IL-22-expressing Lymphocytes Using Reporter Mice
Published on: January 25, 2017
8.4K
IL-17RA in intestinal inflammation: structure, signaling, function, and clinical application
Song Liu1, Jianan Ren, Jieshou Li
1*Department of Surgery, School of Medicine, Nanjing University, Jinling Hospital, Nanjing, China; and †Department of Medicine, Gastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Inflammatory Bowel Diseases
|October 2, 2014
Summary
Interleukin-17 receptor A (IL-17RA) balances distinct IL-17A and IL-25 signaling pathways, crucial for intestinal immunity. Targeting IL-17RA offers therapeutic potential for mucosal immunology and inflammation.
Area of Science:
- Immunology
- Molecular Biology
- Gastroenterology
Background:
- Interleukin-17 receptor A (IL-17RA) mediates signaling for both IL-17A and IL-25 (IL-17E).
- Distinct yet interactive roles of IL-17A and IL-25 are vital for intestinal immune homeostasis.
- IL-17RA is hypothesized to govern the balance between these pathways, making it key in mucosal immunology.
Purpose of the Study:
- To review the structure of IL-17RA.
- To compare IL-17A and IL-25 signaling.
- To emphasize IL-17RA's function in intestinal inflammation and discuss clinical trials targeting the Th17 pathway.
Main Methods:
- Literature review of IL-17RA structure and function.
- Comparative analysis of IL-17A and IL-25 signaling pathways.
- Review of clinical trial data for IL-17RA-targeting therapies.
Main Results:
- IL-17RA's structural and functional characteristics are detailed.
- Key differences and interactions between IL-17A and IL-25 signaling are elucidated.
- The role of IL-17RA in maintaining intestinal immune balance and its implication in inflammatory conditions are highlighted.
Conclusions:
- IL-17RA is a critical regulator of intestinal immune homeostasis.
- Understanding IL-17RA signaling is essential for developing targeted therapies for inflammatory diseases.
- Clinical trials targeting IL-17RA show promise for Th17-mediated conditions.
Related Concept Videos
01:24T Cell Types and Functions
3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
01:25Inflammatory Bowel Disease III: Crohn's Disease
19
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
19
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
1.8K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
1.8K
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
20
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
20
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
1.8K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
01:20The JAK-STAT Signaling Pathway
10.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
10.1K